Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Total Current Liabilities (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Total Current Liabilities for 16 consecutive years, with $85.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Total Current Liabilities changed N/A year-over-year to $85.5 million, compared with a TTM value of $85.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $120.4 million, down 22.86% over the prior year.
  • Total Current Liabilities was $85.5 million for Q3 2025 at Cross Country Healthcare, down from $96.2 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $283.2 million in Q1 2022 and bottomed at $85.5 million in Q3 2025.
  • Average Total Current Liabilities over 5 years is $175.9 million, with a median of $150.4 million recorded in 2021.
  • The sharpest move saw Total Current Liabilities surged 132.82% in 2022, then tumbled 51.51% in 2024.
  • Year by year, Total Current Liabilities stood at $199.8 million in 2021, then surged by 39.73% to $279.1 million in 2022, then tumbled by 44.08% to $156.1 million in 2023, then dropped by 22.86% to $120.4 million in 2024, then fell by 28.95% to $85.5 million in 2025.
  • Business Quant data shows Total Current Liabilities for CCRN at $85.5 million in Q3 2025, $96.2 million in Q2 2025, and $109.0 million in Q1 2025.